Search

everythinglearnresearchcommunity

for

Search:↓

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Understanding gene expression in hair follicles can reveal insights into hair growth and disorders.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Spironolactone treatment increases the amount of testosterone available in the body.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

PGD2 stops hair growth and is higher in bald men with AGA.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Some medicinal plants can help heal wounds and may lead to new treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Use minoxidil for hair loss treatment; assess results after 6 months.

Masculine facial features may not reliably indicate heritable health, and more research is needed.